中医药防治经皮腔内冠状动脉成形术后再狭窄的现状和思路  

THE PRESENT SITUATIONS AND THINLING ON TCM PROPHYLAXIS AND TREATMENT OF RESTENOSIS AFTER PTCA

作　　者：张文高[1] 邵念方[2] 管昌益[3] 周苏宁[1] 崔连群[4] 马学盛[1] 江巍[1] 

机构地区：[1]山东中医药大学,山东济南250014 [2]山东中医药大学附属医院,山东济南250011 [3]厦门市中医院 [4]山东省千佛山医院,山东济南250014

出　　处：《山东中医药大学学报》2000年第1期7-9,共3页Journal of Shandong University of Traditional Chinese Medicine

基　　金：山东省科委计划项目 !( No 9712 2 6 2 15 )

摘　　要：简述经皮腔内冠状动脉成形术(PTCA)后再狭窄发生的机制及中医药防治再狭窄研究的现状。介绍了心脉通胶囊(人参、何首乌、水蛭、丹参等)用于临床防治再狭窄的效果,表明心电图或蹬车试验复查异常率及主要症状复发率,均显著低于对照组;并报告了心脉通胶囊6项基础实验研究的结果。提出气阴两虚、血瘀痰阻是PTCA后再狭窄发生的基本中医病机,并对中医药防治再狭窄的思路进行了讨论。The mechanism of restenosis after percutaneous transluminal coronary angioplasty(PTCA) was analysed,and the present situations of its TCM prophylaxis and treatment were expounded in the thesis.Patients with restenosis after PTCA were treaed with Xinmaitong capsule effectively.The recurrent rate of main symptoms of the diease,the abnormal rates of ECG or bicycle exercise test in the treatment group were all markedly tower than that in the control group.It was put forward that deficiency of Qi Yin,blockage of phlegm and blood stasis may be the TCM pathogenesis of restenosis after PTCA. [

关 键 词：PTCA 术后 再狭窄 防治 中药 心脉通胶囊 

分 类 号：R259.414[医药卫生—中西医结合] R286.2[医药卫生—中医内科学]